GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Integrated Diagnostics Holdings IDHC.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.46p

0.00%

Close of 20 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Integrated Diagnostics Holdings — daily IDHC

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Integrated Diagnostics Holdings on TradingView ↗
Market value
£2.7m
Last close × shares
Volume
7.8k
Shares, 20 Nov 2026
Price to earnings
11.7
Dividend yield
7.35%

About Integrated Diagnostics Holdings

Its shares trade on LSE under the ticker IDHC.L. It has been listed since 6 May 2015. In the fiscal year to 31 December 2025, it reported revenue of EGP 7.86bn and net income of EGP 1.26bn. At that date it held total assets of EGP 8.60bn and shareholders' equity of EGP 3.38bn.

Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in three geographic areas: Egypt, Sudan and Jordan. The firm provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The firm offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The firm's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The firm also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.

Figures and description from our data supplier, not checked against the company's own report.

More about Integrated Diagnostics Holdings →

Latest on Integrated Diagnostics Holdings

Our reporting

We have not reported on Integrated Diagnostics Holdings yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Integrated Diagnostics Holdings's ticker?

Integrated Diagnostics Holdings trades as IDHC.L on LSE, under ISIN JE00BLKGSR75.

What was Integrated Diagnostics Holdings's last closing price?

0.46p on 20 Nov 2026. The figure is in GBp and is never converted.

When does Integrated Diagnostics Holdings next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.